Susquehanna International Group, LLP Alx Oncology Holdings Inc Transaction History

Susquehanna International Group, LLP

$823 Billion
Q3 2025

A detailed history of Susquehanna International Group, LLP transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 113,063 shares of ALXO stock, worth $144,720. This represents 0.0% of its overall portfolio holdings.

Number of Shares

113,063

Previous 163,813 30.98%

Holding current value

$144,720

Previous $68,000 202.94%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$0.44 - $1.87 $22,330 - $94,902	-50,750 Reduced 30.98%	113,063 $206,000
Q2 2025 Aug 14, 2025	BUY	$0.41 - $0.61 $17,262 - $25,682	42,103 Added 34.59%	163,813 $68,000
Q1 2025 May 14, 2025	SELL	$0.62 - $1.86 $18,544 - $55,632	-29,910 Reduced 19.73%	121,710 $75,000
Q4 2024 Feb 14, 2025	BUY	$1.21 - $1.87 $146,739 - $226,778	121,272 Added 399.6%	151,620 $253,000
Q3 2024 Nov 14, 2024	BUY	$1.81 - $8.13 $10,474 - $47,048	5,787 Added 23.56%	30,348 $55,000

Q2 2024 Aug 15, 2024	BUY	$5.84 - $17.56 $5,016 - $15,084	859 Added 3.62%	24,561 $148,000
Q1 2024 May 07, 2024	SELL	$10.95 - $16.79 $173,152 - $265,500	-15,813 Reduced 40.02%	23,702 $264,000
Q4 2023 Feb 14, 2024	SELL	$4.81 - $15.38 $60,456 - $193,311	-12,569 Reduced 24.13%	39,515 $588,000
Q3 2023 Nov 14, 2023	BUY	$4.19 - $7.35 $95,008 - $166,661	22,675 Added 77.1%	52,084 $250,000
Q2 2023 Aug 11, 2023	BUY	$4.37 - $9.56 $74,525 - $163,036	17,054 Added 138.03%	29,409 $220,000
Q1 2023 May 16, 2023	BUY	$4.52 - $11.71 $55,844 - $144,677	12,355 New	12,355 $55,000
Q2 2022 Aug 15, 2022	SELL	$5.89 - $19.46 $177,989 - $588,061	-30,219 Reduced 54.54%	25,193 $204,000
Q1 2022 May 16, 2022	BUY	$13.65 - $22.06 $34,698 - $56,076	2,542 Added 4.81%	55,412 $936,000
Q4 2021 Feb 14, 2022	BUY	$21.49 - $74.4 $795,516 - $2.75 Million	37,018 Added 233.52%	52,870 $1.14 Million
Q3 2021 Nov 15, 2021	SELL	$52.51 - $80.91 $331,285 - $510,461	-6,309 Reduced 28.47%	15,852 $1.17 Million
Q2 2021 Aug 11, 2021	SELL	$52.2 - $75.23 $683,245 - $984,685	-13,089 Reduced 37.13%	22,161 $1.21 Million
Q1 2021 May 17, 2021	BUY	$62.84 - $87.68 $1.89 Million - $2.64 Million	30,068 Added 580.24%	35,250 $2.6 Million
Q4 2020 Feb 16, 2021	BUY	$34.11 - $112.26 $176,758 - $581,731	5,182 New	5,182 $447,000

Others Institutions Holding ALXO

# of Institutions

Shares Held

30.3M

Call Options Held

173K

Put Options Held

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $52.2M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Alx Oncology Holdings Inc Transaction History